BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 11075577)

  • 1. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
    Rovira Cañellas A
    Neurologia; 2000; 15(7):288-302. PubMed ID: 11075577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
    Rovira A; León A
    Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R; Sepcić J
    Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical-magnetic resonance imaging correlations in multiple sclerosis.
    Zivadinov R; Leist TP
    J Neuroimaging; 2005; 15(4 Suppl):10S-21S. PubMed ID: 16385015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Magnetic resonance imaging in multiple sclerosis].
    Tourbah A; Berry I
    Pathol Biol (Paris); 2000 Mar; 48(2):151-61. PubMed ID: 10815291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on multiple sclerosis.
    Simon JH
    Radiol Clin North Am; 2006 Jan; 44(1):79-100, viii. PubMed ID: 16297683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal cord imaging in multiple sclerosis.
    Tench CR; Morgan PS; Jaspan T; Auer DP; Constantinescu CS
    J Neuroimaging; 2005; 15(4 Suppl):94S-102S. PubMed ID: 16385022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.
    Bakshi R; Dandamudi VS; Neema M; De C; Bermel RA
    J Neuroimaging; 2005; 15(4 Suppl):30S-45S. PubMed ID: 16385017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging advances in multiple sclerosis.
    Bakshi R
    J Neuroimaging; 2005; 15(4 Suppl):5S-9S. PubMed ID: 16385014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MRI visualization of multiple sclerosis lesions].
    Berry I; Ranjeva JP; Manelfe C; Clanet M
    Rev Neurol (Paris); 1998 Sep; 154(8-9):607-17. PubMed ID: 9809376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multiple sclerosis and magnetic resonance].
    Jinochová M; Seidl Z; Obenberger J; Krásenský J; Havrdová E; Viták T; Peterová V; Danes J
    Cas Lek Cesk; 2003 Mar; 142(3):144-9. PubMed ID: 12756841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations for using and interpreting magnetic resonance imaging in multiple sclerosis].
    Rovira A; Tintoré M; Alvarez-Cermeño JC; Izquierdo G; Prieto JM
    Neurologia; 2010 May; 25(4):248-65. PubMed ID: 20609303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI in multiple sclerosis.
    Simon JH
    Phys Med Rehabil Clin N Am; 2005 May; 16(2):383-409, viii. PubMed ID: 15893678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI to monitor treatment efficacy in multiple sclerosis.
    Fazekas F; Soelberg-Sorensen P; Comi G; Filippi M
    J Neuroimaging; 2007 Apr; 17 Suppl 1():50S-55S. PubMed ID: 17425736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution.
    Inglese M; Grossman RI; Filippi M
    J Neuroimaging; 2005; 15(4 Suppl):22S-29S. PubMed ID: 16385016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
    Zivadinov R
    Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple sclerosis: imaging, diagnostic criteria and differential diagnosis].
    Harting I; Sellner J; Meyding-Lamadé U; Sartor K
    Rofo; 2003 May; 175(5):613-22. PubMed ID: 12743852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis.
    Neema M; Stankiewicz J; Arora A; Dandamudi VS; Batt CE; Guss ZD; Al-Sabbagh A; Bakshi R
    J Neuroimaging; 2007 Apr; 17 Suppl 1():16S-21S. PubMed ID: 17425729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spinal cord magnetic resonance imaging in multiple sclerosis: importance of determining degree of atrophy as a marker of disease course].
    De Seze J; Ayachi M; Stojkovic T; Gauvrit JY; Saint Michel T; Pruvo J; Vermersch P
    Rev Neurol (Paris); 2000 May; 156(5):491-6. PubMed ID: 10844368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.